CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Tanay Loya
/ Categories: Trending, Markets

Thyrocare Technologies to consider share buyback; stock surges

Thyrocare Technologies gained over 7.5 per cent in the early morning trade on Monday as the company announced plans to consider buyback of shares.

The company informed the exchanges that a meeting of its Board of Directors will be held on August 04, 2018 to consider a proposal to buyback equity shares of the company.

The meeting will also discuss postponing its 18th Annual General Meeting, scheduled to be held on August 11, 2018 to a later date, to enable the shareholders to consider the aforesaid proposal, the company added.

At 14:53 hours, Thyrocare Technologies was trading at Rs. 629.50 per share, up Rs. 39.55 or 6.4 per cent on NSE, on Monday. The stock opened at Rs. 619.80 from a previous close of Rs. 589.95 and touched an intraday high of Rs. 635 per share on NSE. So far, the stock has attracted a traded volume of 1,07,680 shares against a 10-day average volume of 9,781 shares on NSE.

Previous Article Bank of Baroda surges on strong Q1FY19 results
Next Article Vanta Bioscience announces foray into clinical research
Print
2007 Rate this article:
3.5
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR